Amy Dyken, controller at Metlock Pharmaceutical Industries, a public company, is currently preparing the calculation for basic and diluted earnings per share and the related disclosure for Metlock's financial statements. Below is selected financial information for the fiscal year ended June $30,2025.$

Metlock Pharmaceutical Industries

Selected Balance Sheet Information June $30,2025$

Long$-$term debt

Notes payable, $10\%$

$9\%$ convertible bonds payable

$10\%$ bonds payable

Total long$-$term debt

$\backslash$table$[[5,940,000$